Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Every few months a new analysis lands with the same headline: launch prices for new drugs outpace inflation. The latest reported that the median net launch price for 154 medicines rose 51 percent from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results